We used to and maybe still do pay an Irish based pharma consultant, Breffni Martin, so this and that can be looked at in our pipe by EU companies/universities etc. It's very possible it was all just to protect MANF and move things along in the baltics while we were on the ropes, but connecting some dots, the article pushed out by Dr. Weiss there mentions Dublin based United Neuroscience, who just had a positive P2 in Alzheimers who look at the earlier stages of Alzheimers. Perhaps United will elect for Lympro for their late-stage trials if our second Lympro 2.0 turns out well.